Skip to content

Drug interactions

Ozanimod + Rolapitant

Severity: Moderate

Ozanimod and Rolapitant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rolapitant inhibits BCRP and may raise exposure to the active metabolites of ozanimod. This could increase ozanimod adverse effects such as bradycardia, hepatic enzyme elevation and infection risk.

What this interaction means in plain words

Ozanimod and Rolapitant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Ozanimod belongs to Central Nervous System; Rolapitant belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Rolapitant inhibits intestinal BCRP, which may increase absorption and exposure of ozanimod active metabolites.

What to do

Monitor heart rate, liver enzymes and signs of adverse effects when rolapitant is used with ozanimod. Rolapitant is given as a single dose per chemotherapy cycle, so the exposure is limited.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ozanimod and Rolapitant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ozanimod with Rolapitant?

MediHelp rates the interaction as moderate. Ozanimod and Rolapitant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rolapitant inhibits BCRP and may raise exposure to the active metabolites of ozanimod. This could increase ozanimod adverse effects such as bradycardia, hepatic enzyme elevation and infection risk.

How serious is the interaction between Ozanimod and Rolapitant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate, liver enzymes and signs of adverse effects when rolapitant is used with ozanimod. Rolapitant is given as a single dose per chemotherapy cycle, so the exposure is limited.

What other medicines interact with Rolapitant?

MediHelp also lists interactions of Rolapitant with, for example, Pimozide, Thioridazine, Atomoxetine. The full list is on the Rolapitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in